21st Annual NATA Symposium Scientific Programme
SESSION 1A
SAFETY OF BLOOD AND BLOOD PRODUCTS
Chairs: Maria Beatrice Rondinelli, Rome, Italy; Helen V. New, London, UK; Cheuk-Kwong Lee, Hong Kong, China
Transfusion-related immunomodulation – theoretical or clinically relevant?
David Baron, Vienna, Austria
Pathogen testing in 2021 – what is necessary?
Maria Beatrice Rondinelli, Rome, Italy
Age of blood – problem solved or ongoing debate?
Philip C. Spinella, St. Louis, MO, USA
Discussion
SESSION 2A
HOT TOPICS I – CLINICAL TRANSFUSION PRACTICE
Chairs: Jens Meier, Linz, Austria; Young Jin Yuh, Seoul, South Korea; Alexander Vlaar, Amsterdam, The Netherlands
How to approach liberal vs. restrictive transfusion
Anders Møller, Slagelse, Denmark
Transfusion strategy in myocardial infarction – REALITY trial
Philippe Gabriel Steg, Paris, France
Whole blood – now or never?
Jakob Stensballe, Copenhagen, Denmark
Discussion
Best Poster session
BEST POSTERS ‒ ORAL COMMUNICATIONS (PART 1)
Chairs: Jens Meier, Linz, Austria; Helen V. New, London, UK
Erythrocytes inhibit T-cell activation by modulation of redox state
Marlene C. Gerner, Vienna, Austria
Intraoperative cell salvage as an alternative to allogeneic blood transfusion: an evaluation of the immune response profile
Michelle Roets, Brisbane, QLD, Australia
Combined intraoperative platelet and erythrocyte salvage: first evaluation of a new autotransfusion device
Alexandre Mansour, Rennes, France
Cell salvage: A decade of haemovigilance reporting in the UK
Sarah Haynes, Manchester, UK
Discussion
Best Poster session
BEST POSTERS ‒ ORAL COMMUNICATIONS (PART 2)
Chairs: Elvira Bisbe, Barcelona, Spain; Ignacio Sarmiento Goldberg, Providencia, Chile
Blood donation and transfusion during the first wave of COVID-19 pandemic in Spain: different impact according to autonomous communities and hospitals
José Antonio García-Erce, Pamplona, Spain
McCluskey risk index application to blood transfusion needs in liver transplantation at Coimbra Hospital and University Center ‒ Is blood transfusion no more unpredictable?
Sílvia Amaral, Coimbra, Portugal
Should we continue routine preoperative blood ordering in orthopaedic surgery?
Eva Bassas Parga, Barcelona, Spain
A descriptive Blood sample Volume Analysis in a Multidisciplinary Pediatric Intensive caRE unit (B-VAMPIRE)
Tine François, Montreal, QC, Canada
Discussion
SESSION 3A
PATIENT BLOOD MANAGEMENT – WHAT I HAVE TO KNOW AS A TRAINEE
Chairs: Elvira Bisbe, Barcelona, Spain; Nicole R. Guinn, Durham, NC, USA; Hanne Berg Ravn, Copenhagen, Denmark
The basics of PBM – pillar 1
Ane Abad Motos, Madrid, Spain
The basics of PBM – pillar 2
Dania Fischer, Frankfurt, Germany
The basics of PBM – pillar 3
Tina Tomić Mahečić, Zagreb, Croatia
Discussion
SESSION 4A
HOT TOPICS II – PBM RESEARCH AND IMPLEMENTATION
Chair: Sigismond Lasocki, Angers, France; Christian von Heymann, Berlin, Germany; José A. García-Erce, Pamplona, Spain
Top 5 most important PBM publications in 2020–2021
David Faraoni, Toronto, ON, Canada
RCTs in PBM – do they give us all the answers?
Kevin Trentino, Perth, WA, Australia
Maturity Assessment in PBM – monitoring implementation at the national level
Elvira Bisbe, Barcelona, Spain
Discussion
SESSION 3B
PATIENT BLOOD MANAGEMENT – WHAT I HAVE TO KNOW AS A TRAINEE
Chairs: Sigismond Lasocki, Angers, France; Jameela Sathar, Selangor, Malaysia; Giovanni Inghilleri, Milan, Italy
The basics of PBM – pillar 1
Ane Abad Motos, Madrid, Spain
The basics of PBM – pillar 2
Dania Fischer, Frankfurt, Germany
The basics of PBM – pillar 3
Tina Tomić Mahečić, Zagreb, Croatia
Discussion
SESSION 4B
HOT TOPICS II – PBM RESEARCH AND IMPLEMENTATION
Chair: Manuel Muñoz, Málaga, Spain; Daniela Filipescu, Bucharest, Romania; Jeong-jae Lee, Seoul, South Korea
Top 5 most important PBM publications in 2020–2021
David Faraoni, Toronto, ON, Canada
RCTs in PBM – do they give us all the answers?
Kevin Trentino, Perth, WA, Australia
Maturity Assessment in PBM – monitoring implementation at the national level
Elvira Bisbe, Barcelona, Spain
Discussion
SESSION 1B
SAFETY OF BLOOD AND BLOOD PRODUCTS
Chairs: Beverley J. Hunt, London, UK; Jeannie Callum, Toronto, ON, Canada; Jerrold H. Levy, Durham, NC, USA
Transfusion-related immunomodulation – theoretical or clinically relevant?
David Baron, Vienna, Austria
Pathogen testing in 2021 – what is necessary?
Maria Beatrice Rondinelli, Rome, Italy
Age of blood – problem solved or ongoing debate?
Philip C. Spinella, St. Louis, MO, USA
Discussion
SESSION 2B
HOT TOPICS I – CLINICAL TRANSFUSION PRACTICE
Chairs: Jean-François Hardy, Montreal, QC, Canada; Jeffrey L. Carson, New Brunswick, NJ, USA; Ludhmila Abrahão Hajjar, São Paulo, SP, Brazil
How to approach liberal vs. restrictive transfusion
Anders Møller, Slagelse, Denmark
Transfusion strategy in myocardial infarction – REALITY trial
Philippe Gabriel Steg, Paris, France
Whole blood – now or never?
Jakob Stensballe, Copenhagen, Denmark
Discussion
SESSION 5A
CELL SALVAGE – OUTDATED OR UP TO DATE?
Chairs: Toby Richards, Perth, WA, Australia; Jonghyeon Lee, Seoul, South Korea; Thomas Frietsch, Mannheim, Germany
Cell salvage in paediatrics
Susan M. Goobie, Boston, MA, USA
Cell salvage in the bleeding trauma patient
Lidia Mora Miquel, Barcelona, Spain
Cell salvage in cancer surgery – a no go?
Timo Seyfried, Regensburg, Germany
Discussion
SESSION 6A
HOT TOPICS III – PERIOPERATIVE ANAEMIA AND IRON DEFICIENCY
Chairs: Maria Beatrice Rondinelli, Rome, Italy; Dongho Choi, Seoul, South Korea; Bernd Froessler, Adelaide, SA, Australia
The anaemia clinic – a must for every hospital
Elvira Bisbe, Barcelona, Spain
Preoperative IV iron in major abdominal surgery: PREVENTT trial
Toby Richards, Perth, WA, Australia
EPO – a new kid on the block?
Sigismond Lasocki, Angers, France
Discussion
SESSION 7A
PATIENT BLOOD MANAGEMENT – A POLITICAL ISSUE?
Chairs: Jens Meier, Linz, Austria; Aryeh Shander, Englewood, NJ, USA, Marcel Levi, London, UK
WHO Action framework for blood products – focus on PBM
Yuyun Maryuningsih, Geneva, Switzerland
Levels of PBM implementation – a global view
Axel Hofmann, Zurich, Switzerland
Stakeholders’ perspectives on PBM
Jens Meier, Linz, Austria
Discussion
SESSION 8
SABM SESSION – A PRACTICAL APPROACH TO PATIENT BLOOD MANAGEMENT
Chairs: Carolyn Burns, Louisville, KY, USA; Charles-Marc Samama, Paris, France; Jean-François Hardy, Montreal, QC, Canada
The role of the surgeon in PBM
Pierre Tibi, Prescott, AZ, USA
The role of a PBM coordinator
Sherri Ozawa, Englewood, NJ, USA
Wind of change – how to initiate PBM in real life?
Aryeh Shander, Englewood, NJ, USA
Discussion
SESSION 7B
PATIENT BLOOD MANAGEMENT – A POLITICAL ISSUE?
Chairs: Elvira Bisbe, Barcelona, Spain; Ananthi Krishnamoorthy, Ipoh, Perak, Malaysia; Kai Zacharowski, Frankfurt, Germany
WHO Action framework for blood products – focus on PBM
Yuyun Maryuningsih, Geneva, Switzerland
Role of the European Union in promoting PBM
Axel Hofmann, Zurich, Switzerland
Stakeholders’ perspectives on PBM
Jens Meier, Linz, Austria
Discussion
SESSION 9
ASPBM SESSION – INSIGHT INTO PATIENT BLOOD MANAGEMENT IN ASIA
Chairs: Jeong-jae Lee, Seoul, South Korea; Jaewhoan Koh, Gyeonggi, South Korea; Jens Meier, Linz, Austria
PBM in South Korea and the birth of ASPBM
Jong-Hoon Park, Seoul, South Korea
PBM in China: a nationwide endeavour
Hongwen Ji, Beijing, China
PBM – the Challenge of unmet needs in Asia
Angelina Gapay, Tacloban City, Leyte, Philippines
Discussion
SESSION 10A
PATIENT BLOOD MANAGEMENT IN THE ICU
Chairs: David Faraoni, Toronto, ON, Canada; Augusto Pérez-Calatayud, Mexico City, Mexico; Howard L. Corwin, Danville, PA, USA
Role of iron and EPO in the ICU
Sigismond Lasocki, Angers, France
Coagulopathies in the ICU
Isabell Pekrul, Munich, Germany
Transfusion triggers for critically ill patients – ESICM guidelines
Alexander P. J. Vlaar, Amsterdam, The Netherlands
Discussion
SESSION 11A
HOT TOPICS IV – BLEEDING AND THROMBOSIS
Chairs: Charles-Marc Samama, Paris, France; Ignacio Sarmiento Goldberg, Providencia, Chile; Fredy Ariza Cadena, Cali, Colombia
When to use tranexamic acid?
Beverley J. Hunt, London, UK
Point-of-care coagulation monitoring – the way to go
Jakob Stensballe, Copenhagen, Denmark
COVID-19, haemostasis and thrombosis
Beverley J. Hunt, London, UK
Discussion
SESSION 10B
PATIENT BLOOD MANAGEMENT IN THE ICU
Chairs: Jens Meier, Linz, Austria; Kiew Kong Pau, Kuala Lumpur, Malaysia; Shunji Kawamoto, Kanagawa, Japan
Role of iron and EPO in the ICU
Sigismond Lasocki, Angers, France
Coagulopathies in the ICU
Isabell Pekrul, Munich, Germany
Transfusion triggers for critically ill patients – ESICM guidelines
Alexander P. J. Vlaar, Amsterdam, The Netherlands
Discussion
SESSION 11B
HOT TOPICS IV – BLEEDING AND THROMBOSIS
Chairs: Charles-Marc Samama, Paris, France; Elisavet Grouzi, Athens, Greece; Byung-Hoon Yoo, Seoul, South Korea
When to use tranexamic acid?
Beverley J. Hunt, London, UK
Point-of-care coagulation monitoring – the way to go
Jakob Stensballe, Copenhagen, Denmark
COVID-19, haemostasis and thrombosis
Beverley J. Hunt, London, UK
Discussion
Best Poster session
BEST POSTERS ‒ ORAL COMMUNICATIONS (PART 3)
Chairs: Sigismond Lasocki, Angers, France; Bernd Froessler, Adelaide, SA, Australia
Iron deficiency reduces mitochondrial respiration and changes mitochondrial morphology in mouse skeletal muscle tissue
Katerina Cabolis, London, UK
A retrospective cohort review of pre-operative anaemia and postoperative outcomes in 1,751 colorectal surgical patients
Charlotte Oliver, Cardiff, Wales, UK
Comparison of two intravenous iron regimens in the treatment of postoperative anaemia after colorectal cancer surgery
Marta De la Rosa-Estadella, Barcelona, Spain
Evaluation of serum phosphate levels in surgical patients receiving intravenous ferric carboxymaltose
Linda K. Wijaya, Perth, WA, Australia
Discussion
Best Poster session
BEST POSTERS ‒ ORAL COMMUNICATIONS (PART 4)
Chairs: Maria Beatrice Rondinelli, Rome, Italy; Jakob Stensballe, Copenhagen, Denmark
The need to screen for anaemia in fit and healthy women
Cory Dugan, Perth, WA, Australia
Charting the course of ‘Gynaemia’ (Patients with Anaemia undergoing Gynaecological Onco-surgery)
Sandaruwani Abeysiri, London, UK
Early plasma transfusion and maternal outcomes in women with postpartum haemorrhage: Does the amount of resuscitation fluids matter?
Johanna van der Bom, Leiden, The Netherlands
Procoagulant membrane dynamics: a novel approach to identify platelet activation in pre-eclampsia
Joshua Nicholas, Calgary, AB, Canada
Discussion
SESSION 5B
CELL SALVAGE – OUTDATED OR UP TO DATE?
Chairs: David Faraoni, Toronto, ON, Canada; Jonathan H. Waters, Pittsburgh, PA, USA; Thorsten Haas, Zurich, Switzerland
Cell salvage in paediatrics
Susan M. Goobie, Boston, MA, USA
Cell salvage in the bleeding trauma patient
Lidia Mora Miquel, Barcelona, Spain
Cell salvage in cancer surgery – a no go?
Timo Seyfried, Regensburg, Germany
Discussion
SESSION 6B
HOT TOPICS III – PERIOPERATIVE ANAEMIA AND IRON DEFICIENCY
Chairs: Manuel Muñoz, Málaga, Spain; Michael Auerbach, Baltimore, MD, USA
The anaemia clinic – a must for every hospital
Elvira Bisbe, Barcelona, Spain
Preoperative IV iron in major abdominal surgery: PREVENTT trial
Toby Richards, Perth, WA, Australia
EPO – a new kid on the block?
Sigismond Lasocki, Angers, France